← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #1430 OF 1,916 MOST-CITED

Understandable language

FDA cited this observation 9 times across 9 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Bioresearch Monitoring9
BY FISCAL YEAR
FY20251
FY20241
FY20232
FY20221
FY20202
FY20191
FY20161

How FDA worded it — real examples

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Natasha Leighl, M.D. · Toronto · Bioresearch Monitoring · 2024-11-22

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Alejandro (NMI) Hoberman, M.D. · Pittsburgh, Pennsylvania · Bioresearch Monitoring · 2024-06-18

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Vladimir A. Guevara Vazquez, M.D. · Miami, Florida · Bioresearch Monitoring · 2023-06-30

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Piangwarin Phaosawasdi, M.D. · Vacaville, California · Bioresearch Monitoring · 2023-05-18

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Stephen G. Kaler, M.D. · Columbus, Ohio · Bioresearch Monitoring · 2022-06-14

The general requirements for informed consent were not met in that the information given was not in language understandable to the subject or the subject's representative.

Allan B. Perel, M.D. · Staten Island, New York · Bioresearch Monitoring · 2020-01-21

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

GCP discipline

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →